Computational Biology And Medical Sciences

Dean’s Award for Outstanding Achievement, Graduate School of Frontier Sciences 2017 2017:03:30:11:49:58
The recipients of the Dean's Award for Outstanding Achievement (Master course 12 students, Doctoral course 12 students) GSFS 2017 were announced. The awards were initiated in 2006 for the purpose of recognizing students and groups for outstanding achievement in academic learning, international exchange, and regional contribution. A ceremony was held on Wednesday March 15, and Dean Takashi Mino awarded plaques to the recipients.
March 30, 2017
Commencement of First-in-Human Clinical Trial for New Molecular Targeting Drug 2016:04:07:22:22:57
TOKYO, Japan (March 22, 2016) –The National Cancer Center, The University of Tokyo, and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced a collaboration to develop a histone methylation enzyme EZH1/2 dual inhibitor (DS-3201), as a new molecular targeting agent for hematologic malignancy, and the commencement of Phase 1 clinical trial in patients with malignant lymphoma and adult T-cell leukemia-lymphoma (ATL).
April 7, 2016
August 17, 2015
August 17, 2015
Visualizing RNAi at work 2015:07:03:9:27:23
University of Tokyo and Kyoto University researchers have revealed the molecular mechanism of RNA interference (RNAi), the phenomenon by which the synthesis of a specific protein is inhibited, by real time observation of target RNA cleavage at the single-molecule level.
July 3, 2015